Autoplaque vs Vista OS
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is detailed, quantitative analysis of coronary plaques and luminal stenoses from existing CT angiography images. This tool is ideal for clinicians focused on precise heart attack risk prediction and guiding treatment strategies based on comprehensive plaque characterization and stenosis measurements.
View Autoplaque →Choose Vista OS if…
Choose Vista OS if your objective is to automate and standardize the cardiac MRI acquisition process, improving workflow efficiency and image consistency. This software is best suited for institutions looking to enhance technologist productivity, reduce scan times, and ensure high-quality cardiac MRI data acquisition across single or multi-site deployments.
View Vista OS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Vista OS |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Vista AI Scan installs on customer-provided hardware and communicates directly with GE and Siemens MRI scanners. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Vista OSVista OS emphasizes ease of use for technologists, with features like automated scan planning in 30 seconds and a simplified workflow requiring 'just a few clicks' [6, 17]. Clinical studies show high voluntary adoption rates among technologists due to its user-friendliness [1]. Autoplaque, while offering clinician-reviewable segmentation, is workstation-based and described as potentially less flexible for widespread deployment [7].
Clinical Value
Vista OSBoth tools are FDA-cleared and offer significant clinical value. However, Vista OS demonstrates a broader impact by significantly reducing cardiac MRI scan times (up to 31% shorter) and improving image consistency across technologists [1, 2]. It also dramatically increases patient access by reducing backlogs from 28 days to 1-day access and enabling more scan slots [2, 8, 21]. Autoplaque provides crucial quantitative analysis for heart attack risk prediction from CTA images, but Vista OS's impact on efficiency, consistency, and accessibility across the entire imaging workflow is more comprehensive [8, 9].
Pricing & Value
TieNeither Autoplaque nor Vista OS publicly discloses its pricing information [6, 8]. Without specific details on their pricing models or costs, it is impossible to conduct a meaningful comparison of their respective value propositions.
Enterprise Readiness
Vista OSVista OS explicitly states it is 'HIPAA-compliant software' with a 'Scalable, Remote-Ready Architecture' designed for 'single- or multi-site deployment with secure remote access' [6]. It integrates with GE and Siemens MRI systems, as well as existing PACS and post-processing software, and offers on-site customer support and training [6, 17]. Autoplaque is workstation-based and lacks explicit public statements regarding HIPAA compliance or BAA, making Vista OS appear more prepared for enterprise environments [7].
Innovation
Vista OSVista OS stands out as the 'only 3rd party software cleared to control MRI systems for image acquisition and reconstruction' [2, 8]. Its AI-powered automation of the entire cardiac MRI acquisition process, including real-time adjustments and remote scanning capabilities, represents a more foundational and transformative innovation in the imaging workflow, addressing staffing shortages and expanding access [2, 6, 21]. Autoplaque's innovation lies in its detailed quantitative post-processing analysis of coronary plaque.
Support & Docs
Vista OSVista OS explicitly mentions 'on-site customer support and training provided by Vista AI' as part of its agreements with healthcare providers [17]. While Autoplaque mentions a user manual, there is a general lack of public information regarding its specific support channels, service level agreements, or comprehensive user documentation [7, 9].
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Vista OS |
|---|---|---|
| Name | Autoplaque | Vista OS |
| Company | Cedars-Sinai Medical Center: AIM | Vista AI, Inc. |
| Description | Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | Vista AI Scan is an FDA-cleared, AI-powered software that automates and simplifies cardiac MRI acquisition, enhancing consistency, productivity, and patient access to high-quality imaging. |
| Primary Imaging Modality | CT Angiography (CTA) | Cardiac MRI |
| Key Functionality | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area | AI-powered automated cardiac MRI acquisition; Automated scan planning & localization in 30 seconds; Parameter tuning for optimal image settings; Real-time motion & artifact detection (on certain sequences); In-line analysis before patient leaves; Compatibility with GE and Siemens MRI systems; Integration with common PACS and post-processing software; AI-driven toolkit for technologists |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Vista OS.